IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 214 filers reported holding IMMUNOMEDICS INC in Q3 2018. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,882,000 | +164.7% | 22,133 | +10.3% | 0.01% | +116.7% |
| Q2 2020 | $711,000 | +336.2% | 20,073 | +66.0% | 0.01% | +200.0% |
| Q1 2020 | $163,000 | -19.7% | 12,093 | +26.0% | 0.00% | 0.0% |
| Q4 2019 | $203,000 | +59.8% | 9,598 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $127,000 | +6.7% | 9,598 | +11.5% | 0.00% | 0.0% |
| Q2 2019 | $119,000 | -27.9% | 8,606 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $165,000 | +42.2% | 8,606 | +5.6% | 0.00% | 0.0% |
| Q4 2018 | $116,000 | -20.5% | 8,151 | +16.3% | 0.00% | 0.0% |
| Q3 2018 | $146,000 | -0.7% | 7,011 | +12.5% | 0.00% | 0.0% |
| Q2 2018 | $147,000 | +61.5% | 6,231 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $91,000 | -9.9% | 6,231 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $101,000 | +42.3% | 6,231 | +22.9% | 0.00% | 0.0% |
| Q3 2017 | $71,000 | +57.8% | 5,069 | 0.0% | 0.00% | – |
| Q2 2017 | $45,000 | +104.5% | 5,069 | +49.3% | 0.00% | – |
| Q1 2017 | $22,000 | +83.3% | 3,396 | 0.0% | 0.00% | – |
| Q4 2016 | $12,000 | +9.1% | 3,396 | 0.0% | 0.00% | – |
| Q3 2016 | $11,000 | +37.5% | 3,396 | 0.0% | 0.00% | – |
| Q2 2016 | $8,000 | 0.0% | 3,396 | 0.0% | 0.00% | – |
| Q1 2016 | $8,000 | -20.0% | 3,396 | 0.0% | 0.00% | – |
| Q4 2015 | $10,000 | -98.2% | 3,396 | -97.7% | 0.00% | -100.0% |
| Q2 2014 | $548,000 | -13.3% | 150,000 | 0.0% | 0.02% | -20.0% |
| Q1 2014 | $632,000 | -45.0% | 150,000 | -40.0% | 0.02% | -47.4% |
| Q4 2013 | $1,150,000 | – | 250,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|